Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

November 08, 2018 08:30 ET | Source: Galimedix

New In Vitro Study Demonstrates Galimedix Therapeutics’ Investigational Compound MRZ-99030 Neutralizes the Reproduction of Misfolded Amyloid-Beta, Thereby Potentially Reducing Synaptotoxic Effects

“Hot Topics” Poster at Society for Neuroscience Conference Suggests Even Highly Diluted Concentrations of MRZ-99030 Prevented Formation of Toxic Amyloid Beta Oligomers KENSINGTON, Md. and SHORASHIM,...
November 08, 2018 03:30 ET | Source: Galimedix

New In Vitro Study Demonstrates Galimedix Therapeutics’ Investigational Compound MRZ-99030 Neutralizes the Reproduction of Misfolded Amyloid-Beta, Thereby Potentially Reducing Synaptotoxic Effects

“Hot Topics” Poster at Society for Neuroscience Conference Suggests Even Highly Diluted Concentrations of MRZ-99030 Prevented Formation of Toxic Amyloid Beta Oligomers KENSINGTON, Md. and SHORASHIM,...